New Frontiers in the Law of Psychedelics
Cannabis Law Report
JULY 9, 2021
Collectively, private investors have poured billions of dollars into these companies, with more money coming from non-profit organizations. Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way.
Let's personalize your content